BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Astellas Pharma Canada, Inc. 

675 Cochrane Drive, Suite 500
West Tower
Markham  Ontario  L3R 0B8  U.S.A.
Phone: 905-470-7990 or 1-800-575-1382 Fax: 905-470-7799


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Astellas Pharma Canada, Inc. Introduces Myrbetriq™, a New Class of Treatment for Canadian Patients With Overactive Bladder 4/10/2013 9:51:04 AM    More...
Astellas Pharma Canada, Inc. Receives a Notice of Compliance From Health Canada for Myrbetriq™ (Mirabegron) 3/8/2013 9:42:54 AM    More...
Canadian Urological Association Partners with Astellas Pharma Canada, Inc. 3/29/2012 8:46:41 AM    More...
Astellas Pharma Canada, Inc. (JOBS) and Theravance, Inc. (THRX) (JOBS) Announce Approval of VIBATIV(TM) in Canada for the Treatment of Complicated Skin and Skin Structure Infections 10/1/2009 6:33:49 AM    More...
Simple Blood Test to Identify Organ Rejection; Astellas Pharma Canada, Inc. Joins the PROOF Centre of Excellence to Fund Innovative Research 7/23/2009 10:58:22 AM    More...
Astellas Adds CNS Therapy Area Leader to Global R&D Team 6/4/2009 9:12:41 AM    More...
Astellas Pharma Canada, Inc. Release: Solifenacin Shows Superior Tolerability Compared to Oxybutynin Immediate-Release (IR) 5/1/2009 12:13:41 PM    More...